GSK's antibody drug sotrovimab works against Omicron mutations
Preclinical data demonstrate sotrovimab, authorised in multiple countries around the world, retains activity against all tested variants of concern, including key mutations of Omicron
Preclinical data demonstrate sotrovimab, authorised in multiple countries around the world, retains activity against all tested variants of concern, including key mutations of Omicron
One of the very few facilities in India to have this capability, marking a remarkable feat in LifeCell’s expedition to take genome sequencing to the next level in India
According to a survey conducted by FOGSI last year, 92% of the doctors opined that anaemia due to iron deficiency can be eradicated in five years
ALASTIN’s patented, differentiated technology and products are highly synergistic with Galderma’s premium portfolio
This collaborative nursing conference generated a positive dialogue on how the healthcare space of nursing has evolved in the past year
According to the Russian Direct Investment Fund (RDIF), the Russian Sputnik V and Sputnik Light vaccines have proven to be highly effective against all variants of SARC-Cov-2
The Omicron variant doesn't escape RTPCR and RAT; States advised to ramp up testing for prompt and early identification of any cases
The company has has 10 existing labs in India
Share of government health expenditure in total health expenditure increases to 40.8% (2017-18) from 28.6% (2013-14)
The campaign aims to increase awareness about Tuberculosis as a curable disease and promote early diagnosis.
Subscribe To Our Newsletter & Stay Updated